GTR Home > Tests > Search results - Multiple fibrofolliculomas

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 2406 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C0346010[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 32 tests for 1 condition in 13 labs

CBirt-Hogg-Dube syndrome

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCystic Lung Disease Panel (8 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (12)
Total targets (8)

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CBirt-Hogg-Dube Syndrome via the FLCN Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CepiSEEK® Comprehensive Sequence Analysis for Epilepsy and Seizure Disorders (489 genes)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (641)
Total targets (439)

CCancer Panel, Hereditary, Sequencing 46 Genes, Deletion/Duplication, 47 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (36)
Total targets (47)

CRenal Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 15 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (14)
Total targets (15)

CFLCN

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CRenal/Kidney NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (72)
Total targets (22)

CFLCN. Detection of the mutations c.1285delC y c.1285dupC by sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • T Targeted variant analysis

CFLCN. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCystic Lung Disease: Sequencing Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Total conditions (16)
Total targets (8)

CHereditary Cancer Syndrome: Sequencing Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (107)
Total targets (46)

CPulmonary Disease: Comprehensive Sequencing Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Total conditions (72)
Total targets (55)

CKidney Renal Cancer NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (83)
Total targets (19)

CIntellectual Disability NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (752)
Total targets (392)

CLung Disorders NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (86)
Total targets (51)

CHereditary Cancer NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (256)
Total targets (112)

CEpilepsy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (598)
Total targets (343)

Showing 1 to 20 of 32 tests for 1 condition in 13 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.